Each year, nearly sixty thousand premature babies in the United States are born with very low birth weight and one out of five of those children have a life threatening opening in the heart. Anthony Daly, whose baby was born prematurely with a heart defect and needed urgent treatment, joins us in this program along with Dr. Evan Zahn who implanted a device smaller than a pea in Baby Tony’s heart to help him survive his condition.
Parents today are faced with countless decisions concerning the care of their children. Dr. Joe Castellano, D.D.S., President of the American Academy of Pediatric Dentistry and the Big Authority on Little Teeth, shares simple tips and tricks for keeping your children’s teeth healthy. He also shares findings from a new national survey that uncovers attitudes and beliefs, along with misconceptions and myths, around pediatric oral care and little teeth.
Beth Davidson, DNP, ACNP, CHFN, CCRN, a nurse practitioner who specializes in heart failure management in Nashville, TN, and heart failure patient Michele N, discuss the problem of heart failure, providing insight into the impact on African Americans specifically, the symptoms, and managing the condition.
PolarityTE’s Denver Lough, MD, PhD, discusses the company’s new approach to treating burns with SkinTE (“autologous” tissue – meaning it comes from the patient being treated, significantly decreasing the chance for rejection by the immune system), the need for additional treatments in this area and case studies to highlight the efficacy of SkinTE.
Dr. William A. Haseltine, scientist, businessman, an expert in biotechnology and healthcare system development, discusses his upcoming book, “WORLD CLASS: A Story of Adversity, Transformation, and Success at NYU Langone Health (Fast Company Press; Feb. 12, 2019). This book highlights the remarkable turnaround and success of NYU Langone Health.
Dr. Michael Ison from the Feinberg School of Medicine at Northwestern University discusses the current flu season as well as the latest information in flu prevention and treatment options, including the new drug Xofluza (Baloxavir Marboxil) by Genentech.
Dr. Jonathan Sorof, M.D., Senior Vice President, Medical and Regulatory Affairs at Global Blood Therapeutics (GBT), discusses the disparities in care that people with sickle cell disease (SCD) live with and what can be done to help change that.
Dr. Joan Mannick, Co-Founder, Chief Medical Officer of resTORbio, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases, discusses their lead program that is selectively targeting TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiovascular and central nervous systems.
Dr. Harold Minkowitz discusses a potential breakthrough in non-opioid post-surgery pain management called HTX-011.
A new study showed that by combining HTX-011 with over-the-counter pain medications, such as Acetaminophen and Ibuprofen, 90% of patients do not require any opioids to manage their post-operative pain for 72 hours after surgery or even needed a discharge prescription for opioids. Above that, 81% of the patients involved in the said study remained completely opioid-free up to 8 days after surgery.
Listen to this podcast episode to get more details.